$33.84
3.48% yesterday
Nasdaq, Dec 23, 10:00 pm CET
Why the stock moved Why the stock moved Beta
ISIN
US90184D1000
Symbol
TWST

Twist Bioscience Corp. Stock price

$33.84
+4.51 15.38% 1M
-1.49 4.22% 6M
-12.63 27.18% YTD
-14.28 29.68% 1Y
+10.65 45.93% 3Y
-132.92 79.71% 5Y
+19.84 141.71% 10Y
+19.84 141.71% 20Y
Nasdaq, Closing price Tue, Dec 23 2025
-1.22 3.48%
ISIN
US90184D1000
Symbol
TWST
Industry

New AI Insights on Twist Bioscience Corp. Insights AI Insights on Twist Bioscience Corp.

How does the company make money?
Who are the company’s main competitors?
What are the key opportunities and risks?
How is the company managed?

Key metrics

Basic
Market capitalization
$2.1b
Enterprise Value
$1.8b
Net debt
positive
Cash
$232.4m
Shares outstanding
60.6m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
5.5 | 4.8
EV/Sales
4.9 | 4.2
EV/FCF
negative
P/B
4.4
Financial Health
Equity Ratio
73.7%
Return on Equity
-16.4%
ROCE
-24.8%
ROIC
-35.6%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$376.6m | $433.8m
EBITDA
$-111.4m | $-36.1m
EBIT
$-136.3m | $-96.6m
Net Income
$-77.7m | $-93.3m
Free Cash Flow
$-75.6m
Growth (TTM | estimate)
Revenue
20.3% | 15.2%
EBITDA
22.9% | 67.6%
EBIT
22.5% | 29.1%
Net Income
62.8% | -20.1%
Free Cash Flow
-9.3%
Margin (TTM | estimate)
Gross
50.7%
EBITDA
-29.6% | -8.3%
EBIT
-36.2%
Net
-20.6% | -21.5%
Free Cash Flow
-20.1%
More
EPS
$-1.3
FCF per Share
$-1.2
Short interest
23.5%
Employees
923
Rev per Employee
$410.0k
Show more

Is Twist Bioscience Corp. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,085 stocks worldwide.

Twist Bioscience Corp. Stock Analysis

Unlock Scores for Free

Analyst Opinions

17 Analysts have issued a Twist Bioscience Corp. forecast:

14x Buy
82%
3x Hold
18%

Analyst Opinions

17 Analysts have issued a Twist Bioscience Corp. forecast:

Buy
82%
Hold
18%

Financial data from Twist Bioscience Corp.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
377 377
20% 20%
100%
- Direct Costs 186 186
3% 3%
49%
191 191
43% 43%
51%
- Selling and Administrative Expenses 247 247
13% 13%
66%
- Research and Development Expense 80 80
12% 12%
21%
-111 -111
23% 23%
-30%
- Depreciation and Amortization 25 25
21% 21%
7%
EBIT (Operating Income) EBIT -136 -136
23% 23%
-36%
Net Profit -78 -78
63% 63%
-21%

In millions USD.

Don't miss a Thing! We will send you all news about Twist Bioscience Corp. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Twist Bioscience Corp. Stock News

Neutral
Business Wire
6 days ago
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience, will present at the J.P. Morgan 2026 Healthcare Conference on Monday, January 12, 2026 at 2:15 pm Pacific Time in San Francisco. The presentation will be webcast live and can ...
Neutral
Business Wire
12 days ago
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Twist Bioscience Corporation (NASDAQ: TWST) breached their fiduciary duties to shareholders. If you currently own Twist stock and are a long-term shareholder, you may be able to seek corporate governance reforms, the return of funds back to the company, a court-ap...
Neutral
Business Wire
20 days ago
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today launched research-grade Plasmid DNA Preps designed to support the advancement of pharmaceutical and biotech customers' pre-clinical studies. “Our new plasmid preps combine the quality and consistency needed for preclinical research with the speed and cost ...
More Twist Bioscience Corp. News

Company Profile

Twist Bioscience Corp. develops proprietary semiconductor-based synthetic DNA manufacturing process. It produces synthetic biology tools such as genes, oligo pools, variant libraries, DNA data storage and NGS. The company also produces agriculture production as well as new applications such as in vivo diagnostics, biodetection and data storage. Twist Bioscience was founded by William Marine Banyai, Emily Marine Leproust and Bill James Peck in February 2013 and is headquartered in San Francisco, CA.

Head office United States
CEO Emily Leproust
Employees 923
Founded 2013
Website www.twistbioscience.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today